Sergio Faria
Papers
1
Total Citations
21
H-Index
1
About
Sergio Faria is a leading radiation oncologist whose research focuses on optimizing stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC). His most cited work, a 2020 study comparing local control and distant metastasis rates between CyberKnife and conventional SBRT, has garnered 21 citations and directly informs clinical decision-making for early-stage lung cancer patients. Faria’s contributions center on refining radiation delivery techniques to improve tumor control while minimizing toxicity, particularly through comparative effectiveness research that evaluates advanced technologies against standard protocols. His work has helped clarify the role of robotic radiosurgery in achieving superior local control, with implications for reducing metastatic progression. Beyond this landmark study, Faria has published extensively on SBRT outcomes, dose fractionation, and patient selection criteria, shaping practice guidelines in thoracic radiation oncology. His research is characterized by rigorous methodology and a patient-centered focus, bridging technical innovation with real-world clinical impact. For students and researchers, Faria exemplifies how comparative studies can drive evidence-based advancements in cancer care, demonstrating the critical importance of balancing technological precision with therapeutic efficacy.
Research Focus
Key Achievements
Top Papers
- 1